Immunological gene therapy with ex vivo gene-modified tumor cells: a critique and a reappraisal.
about
Effects of recombinant adenovirus-mediated expression of IL-2 and IL-12 in human B lymphoma cells on co-cultured PBMCThe Dichotomy of Tumor Exosomes (TEX) in Cancer Immunity: Is It All in the ConTEXt?Insight to drug delivery aspects for colorectal cancerImmunomodulatory gene therapy for haematological malignancies.Progress and limitations in cancer gene therapy.Prevention of hepatocellular carcinoma in mice by IL-2 and B7-1 genes co-transfected liver cancer cell vaccinesImproved antitumour immunity in murine neuroblastoma using a combination of IL-2 and IL-12.Low-dose interferon-gamma-producing human neuroblastoma cells show reduced proliferation and delayed tumorigenicity.The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon.Therapy-induced antitumor vaccination in neuroblastomas by the combined targeting of IL-2 and TNFalpha.In vivo anti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA.Concurrent delivery of tumor antigens and activation signals to dendritic cells by irradiated CD40 ligand-transfected tumor cells resulted in efficient activation of specific CD8+ T cells.Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levels.Immunotherapy for murine K1735 melanoma: combinatorial use of recombinant adenovirus expressing CD40L and other immunomodulators.Complete tumor prevention by engineered tumor cell vaccines employing nonviral vectors.Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines.Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern.
P2860
Q24793078-6D445DA8-8D73-44F3-9B44-B80567A0826CQ26773307-4BCB6AED-4CE7-4E5F-8DBC-95E023126A39Q26774682-F9D78999-52A9-4901-AAC9-3BB890BEDA55Q34579664-3F2B0DB9-8041-4458-BDF1-4DC2CACDFB3BQ35051969-B71114F3-9EA2-4DDE-8B6A-AAE24467C683Q36308644-6EC1B580-47AE-4895-9905-B48EB8D8A8FEQ36648910-2DC9E30A-120A-4F87-9841-DA831745AFD1Q36694271-740181D2-E5A1-4D34-A6F9-CBD98854CDA5Q37561072-843AE5F8-8AE8-43E9-926D-36D89BD253DAQ39781613-E6329C2C-9DEE-4665-BED1-70FAB36BAF92Q40498288-69D8BFAF-D8DB-48DF-BE5C-60FE678266F7Q40546795-5683950A-62EE-465B-B2C9-01DDACD07809Q40744502-4A01604C-87F0-4DA9-A34C-68690C3D0AA2Q44021835-7A931223-D040-4306-9135-A0A2ABBD6C67Q45261752-A76E96F3-6F58-4361-AA3B-FE90B519A09EQ45734835-9F5E31E1-1BA4-4EAD-8BF8-BBA69C7C21C3Q45881367-F2C182F6-7620-4AC8-B89A-61BE9504E7A7
P2860
Immunological gene therapy with ex vivo gene-modified tumor cells: a critique and a reappraisal.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Immunological gene therapy wit ...... a critique and a reappraisal.
@ast
Immunological gene therapy wit ...... a critique and a reappraisal.
@en
type
label
Immunological gene therapy wit ...... a critique and a reappraisal.
@ast
Immunological gene therapy wit ...... a critique and a reappraisal.
@en
prefLabel
Immunological gene therapy wit ...... a critique and a reappraisal.
@ast
Immunological gene therapy wit ...... a critique and a reappraisal.
@en
P2093
P1433
P1476
Immunological gene therapy wit ...... a critique and a reappraisal.
@en
P2093
P304
P356
10.1089/10430340050032375
P577
2000-06-01T00:00:00Z